TVRD

Tvardi Therapeutics

79 hedge funds and large institutions have $4.56M invested in Tvardi Therapeutics in 2024 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 15 increasing their positions, 24 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
79
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$16K
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$204K
2 +$107K
3 +$97.1K
4
Goldman Sachs
Goldman Sachs
New York
+$87.2K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$52K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$581K
2
$499K
3
$439K
4
$402K
5
$278K
6
$275K
7
$222K
8
$192K
9
$151K
10
$123K
11
$122K
12
$114K
13
$107K
14
$101K
15
$97.1K
16
$95.4K
17
$68K
18
$65.6K
19
$57.6K
20
$47.9K
21
$46.6K
22
$45.8K
23
$42K
24
$41.1K
25
$39K